Clinical Trial Update: Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of choline fenofibrate for carotid atherosclerosis in patients with Type 2 diabetes mellitus and combined dyslipidemia; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Choline Fenofibrate (Choline fenofibrate)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Dyslipidemia, Atherosclerosis | Phase 4 | Status: RECRUITING